ABSTRACT
PURPOSE: Preliminary clinical trials employing catheter-based endovascular brachytherapy show promising results in reducing restenosis after coronary intervention. Failure analysis of these studies showed a significant number of failures at the treatment margin. It is hypothesized that one of the possible causes for marginal failure is the longitudinal seed movement during the brachytherapy procedure. In this study a quantitative analysis was performed to determine the magnitude of the source displacement during the cardiac cycle. METHODS AND MATERIALS: Cine-angiograms of the Iridium-192 (Ir-192) active source seeds or dummy source seeds in place were reviewed frame by frame for 30 patients enrolled from various clinical trials using the Cordis catheter delivery system with a Ir-192 seed ribbon. The proximal and distal source points were measured in reference to branching vessels closest to the respective seed during the contrast phase of the cine-angiogram. The two frames showing the maximum source displacement were captured. After appropriate demagnification, longitudinal source displacement was measured. The data were tabulated for proximal vs. distal ends and for different coronary vessels. RESULTS: The longitudinal source displacement is significant with overall mean and standard deviation of 1.1 and 0.8 mm, respectively. The range is from 0.0 to 5.4 mm. CONCLUSION: The contribution of source movement should be included into the treatment length to avoid "geographic miss" and the subsequent marginal failure.
Subject(s)
Brachytherapy/instrumentation , Coronary Disease/radiotherapy , Iridium Radioisotopes/therapeutic use , Angioplasty, Balloon, Coronary , Brachytherapy/methods , Cineangiography , Coronary Disease/diagnostic imaging , Coronary Disease/prevention & control , Foreign-Body Migration/diagnostic imaging , Humans , Secondary Prevention , Treatment FailureABSTRACT
Catheter-based brachytherapy using Ir-192 seed sources has shown significant reduction in the rate of restenosis among patients with coronary in-stent restenosis. High-energy gamma rays from Ir-192 raise some radiation safety issues of personnel. The aim of this study was to fully analyze the radiation safety issues associated with Ir-192 brachytherapy in the cardiac cath lab environment. Measurements were made to assess the penetrating ability of Ir-192 gamma rays through tissues, concrete and lead. Radiation exposure levels were measured around a large number of patients undergoing Ir-192 brachytherapy. Personnel were carefully monitored for any additional dose received from brachytherapy for the last five years covering > 500 cases. Our results showed that with a proper radiation safety program in place, the dose to cath lab staff was negligible. It was concluded that radiation safety of personnel was easy to maintain during catheter-based coronary brachytherapy using Ir-192 seed sources.